Clinical application of sensitive cardiac troponin assays: Potential and limitations

Biomarkers in Medicine

Volumn 4, Issue 3, 2010, Pages 395-401

  Twerenbold, Raphael ^a   Reichlin, Tobias ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute myocardial infarction; Diagnosis; High sensitive troponin; Sensitivity; Specificity

Indexed keywords

BIOLOGICAL MARKER; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; BLOOD SAMPLING; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; EMERGENCY WARD; HEALTH CARE COST; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; MYOCARDITIS; PATIENT MONITORING; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK ASSESSMENT; TAKOTSUBO CARDIOMYOPATHY;

DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 77953739243     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.60     Document Type: Review

References (33)

1. Nawar Ew, Niska Rw, Xu J: National hospital ambulatory medical care survey: 2005 emergency department summary. Adv. Data 386, 1-32 (2007).
2. Anderson JL, Adams CD, Antman EM et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 116(7), e148-e304 (2007).
3. Bassand JP, Hamm CW, Ardissino D et al.: Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J. 28(13), 1598-1660 (2007).
4. Thygesen K, Alpert JS, White HD et al.: Universal definition of myocardial infarction. Circulation 116(22), 2634-2653 (2007). (Pubitemid 350182388)
5. Pope JH, Aufderheide TP, Ruthazer R et al.: Missed diagnoses of acute cardiac ischemia in the emergency department. N. Engl. J. Med. 342(16), 1163-1170 (2000).
6. Wang K, Asinger RW, Marriott HJ: ST-segment elevation in conditions other than acute myocardial infarction. N. Engl. J. Med. 349(22), 2128-2135 (2003).
7. Morrow DA, Cannon CP, Rifai N et al.: Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 286(19), 2405-2412 (2001).
8. Morrow DA, Antman EM, Tanasijevic M et al.: Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J. Am. Coll. Cardiol. 36(6), 1812-1817 (2000).
9. Mueller C, Neumann FJ, Perruchoud AP, Zeller T, Buettner HJ: Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention. Am. J. Med. 117(12), 897-902 (2004). (Pubitemid 40075556)
10. Hochholzer W, Buettner HJ, Trenk D et al.: New definition of myocardial infarction: impact on long-term mortality. Am. J. Med. 121(5), 399-405 (2008).
11. Hamm CW, Heeschen C, Goldmann B et al.: Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. C7e3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) study investigators. N. Engl. J. Med. 340(21), 1623-1629 (1999).
12. Kastrati A, Mehilli J, Neumann FJ et al.: Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295(13), 1531-1538 (2006).
13. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B: Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am. Heart J. 148(4), 574-581 (2004).
14. Mccann CJ, Glover BM, Menown IB et al.: Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur. Heart J. 29(23), 2843-2850 (2008).
15. Macrae AR, Kavsak PA, Lustig V et al.: Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin. Chem. 52(5), 812-818 (2006).
16. Forberg JL, Henriksen LS, Edenbrandt L, Ekelund U: Direct hospital costs of chest pain patients attending the emergency department: a retrospective study. BMC Emerg. Med. 6, 6 (2006).
17. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH: National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 115(13), e352-e355 (2007).
18. Apple FS, Wu AH, Jaffe AS: European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am. Heart J. 144(6), 981-986 (2002).
19. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, Van Dieijen-Visser M: population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin. Chem. 55(1), 101-108 (2008).
20. Melanson SE, Morrow DA, Jarolim P: Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am. J. Clin. Pathol. 128(2), 282-286 (2007).
21. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM: Use of the centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin. Chem. 54(4), 723-728 (2008).
22. Hamm CW: Acute coronary syndromes: the diagnostic role of troponins. Thromb. Res. 103, S63-S69 (2001).
23. Jaffe AS: Chasing troponin: how low can you go if you can see the rise? J. Am. Coll. Cardiol. 48(9), 1763-1764 (2006).
24. Katus HA, Looser S, Hallermayer K et al.: Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin. Chem. 38(3), 386-393 (1992).
25. Ricchiuti V, Apple FS: RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin. Chem. 45(12), 2129-2135 (1999).
26. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PA, Apple FS: Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by boehringer mannheim. Clin. Chem. 44(9), 1919-1924 (1998). (Pubitemid 28405756)
27. Remppis A, Scheffold T, Greten J et al.: Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 27(2), 793-803 (1995).
28. Apple FS: A new season for cardiac troponin assays: it's time to keep a scorecard. Clin. Chem. 55(7), 1303-1306 (2009).
29. Reichlin T, Hochholzer W, Bassetti S et al.: Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361(9), 858-867 (2009).
30. Keller T, Zeller T, Peetz D et al.: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361(9), 868-877 (2009).
31. Omland T, De Lemos JA, Sabatine MS et al.: A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361(26), 2538-2547 (2009).
32. Kelley WE, Januzzi JL, Christenson RH: Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin. Chem. 55(12), 2098-2112 (2009).
33. Morrow DA, Cannon CP, Jesse RL et al.: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115(13), e356-e375 (2007).